Kriba attending the Spanish National Reunion of home peritoneal dialysis and home haemodialysis

Kriba attending the Spanish National Reunion of home peritoneal dialysis and home haemodialysis in Pamplona Feb 22-24 2024. This yearly national meeting is organised by the Spanish Society of Nephrology (S.E.N.) and the Spanish Society of Nephrological Nursing (S.E.D.E.N.) and will bring together more than 400 Nephrology and Nursing professionals, as well as researchers from all over Spain and other prestigious international speakers.

We are honoured that our communication “Detection and monitoring of peritonitis in peritoneal dialysis patients using high-resolution ultrasound and artificial intelligence” has been selected and will be presented by Dr. María Quero, Nephrologist at Bellvitge University Hospital (Barcelona, Spain).  The result presented in this communication are fruit of the clinical collaboration with Bellvitge University Hospital and Kriba, as part of Phase 1 of our ongoing clinical trial to validate Neosonics for early detection and objective home monitoring of peritonitis in peritoneal dialysis (PD) patients.

The full programme in Spanish can be found here (external link).

Training sessions with clinical teams of the Efficacy Phase 2 of the multicentric clinical trial have begun with our clinical partners Hospital Clínic de Barcelona (Spain), University Hospital Moisés Broggi (Barcelona, Spain), University Hospital Consorci Sanitari (Terrassa, Spain) and University Hospital of Navarra (Pamplona, Spain).

Kriba is also collaborating as an exhibiting company during the 3 day event in the Baluarte Convention Center in Pamplona. We will be available to demo our device Neosonics, and present our activity to experts attending the meeting.

We are looking forward to interacting, exchanging, and learning with the national community of home PD experts, and play a part in promoting more flexible and personalised treatment options for patients with chronic kidney disease through home dialysis.

What is dialysis?

When the kidneys are not able to purify the blood, renal replacement therapy is needed. When transplantation (the preferred option) is not possible or not available immediately, dialysis, the treatment that helps the body remove wastes and excess fluid from the blood, is needed.

Peritoneal dialysis and home haemodialysis are modalities of dialysis that can be performed in the patient’s home. Both options are more flexible and personalised than traditional therapies such as in-centre dialysis, and provide multiple clinical benefits, while improving the autonomy and quality of life of people requiring dialysis.

Peritonitis is one of the most relevant complications in PD patients due to its high incidence and associated consequences. Early diagnosis and treatment are essential to minimise the risk of complications.

Kriba is dedicated to enhancing the early detection and infection monitoring of peritonitis for home PD users, making it accessible to improve the lives of those affected by chronic kidney disease.